Stock screenerAll disclosures → EDGAR →
SCNX
Conviction 18HealthcareScan · Mon, Aug 10, 2026Three outside up
SCNX$0.4082+7.39%
ResistanceSupportVol 14Vol MA14 221.19K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price0.4082
Change+7.39%
Gap+3.26%
Rel volume0.01×
Avg volume387.05K
Avg $ vol151.96K
SMA 200.3887
SMA 500.3755
SMA 2000.4808
Price vs 50+8.70%
Price vs 200-15.11%
MA stackmixed
50/200 cross—
Supertrendup · 0.3261
RSI (14)59
MACD hist0.00
MACD crossbull · 0d
Stoch %K / %D87 / 56
ADX (14)9
+DI / −DI20 / 15
RSI divergence—
MACD divergence—
ATR %+6.93%
ADR %7.34%
52w high2.60
52w low0.2409
From 52w high-84.30%
Above 52w low+69.45%
New 52w highNo
SqueezeOn · 4d
Bollinger width16.38%
%B0.81
Donchian pos80.78%
Donchian high0.4250
Donchian low0.3376
AVWAP (52w high)1.40
vs AVWAP high-70.85%
AVWAP (52w low)0.3556
vs AVWAP low+14.79%
OBV trendUp
Chaikin MF (20)0.31
Today vs 20d0.01×
Avg vol (14d)221.19K
Avg vol (20d)387.05K
Avg $ vol (20d)151.96K
Market cap16.59M
RS 3m (vs SPY)-16.24%
RS 6m (vs SPY)-25.72%
RS line new highNo
Trend template2/8
Technical rank44.7
1 week+5.48%
1 month+10.29%
3 months+2.05%
6 months-14.53%
1 year-81.86%
YTD-21.59%
P/E-0.40
P/B0.25
P/S38.43
P/FCF-1.24
EPS-2.70
Div yield—
ROE-62.13%
ROA-51.46%
Debt/Eq0.03
Current1.70
EV/EBITDA-0.28
Gross margin76.80%
Net margin—
Rev growth215.87%
EPS growth-557.90%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value11.92M
Revenue56.33K
Net income-3.4M
Gross profit53.85K
Free cash flow-13.39M
IndustryPharmaceutical Preparations
ExchangeNasdaq
Shares out40.63M
Employees9
ListedFri, Feb 22, 2008
Free float36.78M
Float %90.5%
Short interest2.6M
Days to cover0.3d
Short volume47.8%
Squeeze score21 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction18 / 100
Pattern quality—
Tech rank44.7 / 100
Group rank—
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmThree outside up
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in SCNX
No recent disclosed trades by Congress in SCNX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in SCNX
No recent insider (Form 4) filings in SCNX. Insiders must file within two business days of a trade.
SEC filings
EDGAR filings in SCNX
No recent SEC filings on file for SCNX.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.